{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:03:24Z","timestamp":1757621004520,"version":"3.44.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,8]]},"DOI":"10.7759\/cureus.91824","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:38:52Z","timestamp":1757331532000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Pediatric Arterial Thrombosis in Antiphospholipid Syndrome and Systemic Lupus Erythematosus: A Case Report"],"prefix":"10.7759","author":[{"given":"Isabela","family":"Jimenez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrick","family":"Trelles Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scarleth Samantha","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Zu\u00f1iga Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishell Estefan\u00eda","family":"Llerena Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dajhana Gleidy Di","family":"Valverde Bonilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Valladares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2018.02.001","article-title":"Juvenile-onset systemic lupus erythematosus (jSLE)-pathophysiological concepts and treatment options","volume":"31","author":"Hedrich CM","year":"2017","unstructured":"Hedrich CM, Smith EM, Beresford MW. Juvenile-onset systemic lupus erythematosus (jSLE)-pathophysiological concepts and treatment options. Best Pract Res Clin Rheumatol. 2017, 31:488-504. 10.1016\/j.berh.2018.02.001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2024.101986","article-title":"Antiphospholipid syndrome in children","volume":"38","author":"Zajc Avramovic M","year":"2024","unstructured":"Zajc Avramovic M, Avcin T. Antiphospholipid syndrome in children. Best Pract Res Clin Rheumatol. 2024, 38:101986. 10.1016\/j.berh.2024.101986","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2024.2390637","article-title":"Pediatric antiphospholipid syndrome: is it the same as an adult?","volume":"37","author":"Bitsadze V","year":"2024","unstructured":"Bitsadze V, Khizroeva J, Lazarchuk A, et al.. Pediatric antiphospholipid syndrome: is it the same as an adult?. J Matern Fetal Neonatal Med. 2024, 37:2390637. 10.1080\/14767058.2024.2390637","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.1004053","article-title":"Case report: A case of recurrent thrombosis in pediatric antiphospholipid syndrome associated with pediatric onset systemic lupus","volume":"10","author":"Liu L","year":"2022","unstructured":"Liu L, Liu L, Zhang L, et al.. Case report: A case of recurrent thrombosis in pediatric antiphospholipid syndrome associated with pediatric onset systemic lupus. Front Pediatr. 2022, 10:1004053. 10.3389\/fped.2022.1004053","journal-title":"Front Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-0887-9","article-title":"Pediatric APS: state of the art","volume":"22","author":"Soybilgic A","year":"2020","unstructured":"Soybilgic A, Avcin T. Pediatric APS: state of the art. Curr Rheumatol Rep. 2020, 22:9. 10.1007\/s11926-020-0887-9","journal-title":"Curr Rheumatol Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100788","article-title":"Arterial thrombosis in antiphospholipid syndrome (APS): clinical approach and treatment. A systematic review","volume":"48","author":"Cheng C","year":"2021","unstructured":"Cheng C, Cheng GY, Denas G, Pengo V. Arterial thrombosis in antiphospholipid syndrome (APS): clinical approach and treatment. A systematic review. Blood Rev. 2021, 48:100788. 10.1016\/j.blre.2020.100788","journal-title":"Blood Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejr.2022.07.006","article-title":"Primary and secondary antiphospholipid syndrome characteristics in an Egyptian cohort","volume":"44","author":"Morad CS","year":"2022","unstructured":"Morad CS, Fayez D, Mahmoud M, Aboud FM. Primary and secondary antiphospholipid syndrome characteristics in an Egyptian cohort. Egypt Rheumatol. 2022, 44:373-6. 10.1016\/j.ejr.2022.07.006","journal-title":"Egypt Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/09612033221111955","article-title":"A novel presentation of childhood systemic lupus erythematosus in a 6-year-old child","volume":"31","author":"Wurster A","year":"2022","unstructured":"Wurster A, Bauler L, Howing C, McGlinchey Ford M. A novel presentation of childhood systemic lupus erythematosus in a 6-year-old child. Lupus. 2022, 31:1276-9. 10.1177\/09612033221111955","journal-title":"Lupus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2019.19160","article-title":"Pediatric antiphospholipid syndrome","volume":"7","author":"Madison JA","year":"2020","unstructured":"Madison JA, Zuo Y, Knight JS. Pediatric antiphospholipid syndrome. Eur J Rheumatol. 2020, 7:S3-12. 10.5152\/eurjrheum.2019.19160","journal-title":"Eur J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.108274","article-title":"Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options","volume":"209","author":"Smith EM","year":"2019","unstructured":"Smith EM, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 2019, 209:108274. 10.1016\/j.clim.2019.108274","journal-title":"Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04435-0","article-title":"Clinical characteristics of patients with systemic lupus erythematosus showing a false-positive result of syphilis screening","volume":"39","author":"Ahn SS","year":"2019","unstructured":"Ahn SS, Jung SM, Yoo J, Lee SW, Song JJ, Park YB. Clinical characteristics of patients with systemic lupus erythematosus showing a false-positive result of syphilis screening. Rheumatol Int. 2019, 39:1859-66. 10.1007\/s00296-019-04435-0","journal-title":"Rheumatol Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3776-5","article-title":"Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients","volume":"37","author":"Ma J","year":"2018","unstructured":"Ma J, Song H, Wei M, He Y. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients. Clin Rheumatol. 2018, 37:1295-303. 10.1007\/s10067-017-3776-5","journal-title":"Clin Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.02.058","article-title":"Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics","volume":"69","author":"Corban MT","year":"2017","unstructured":"Corban MT, Duarte-Garcia A, McBane RD, Matteson EL, Lerman LO, Lerman A. Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics. J Am Coll Cardiol. 2017, 69:2317-30. 10.1016\/j.jacc.2017.02.058","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00655-6","article-title":"Correction to: Evaluating the performance of ACR, SLICC and EULAR\/ACR classification criteria in childhood onset systemic lupus erythematosus","volume":"19","author":"Abdwani R","year":"2021","unstructured":"Abdwani R, Al Masroori E, Abdullah E, Al Abrawi S, Al-Zakwani I. Correction to: Evaluating the performance of ACR, SLICC and EULAR\/ACR classification criteria in childhood onset systemic lupus erythematosus. Pediatr Rheumatol Online J. 2021, 19:165. 10.1186\/s12969-021-00655-6","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-211001","article-title":"European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative","volume":"76","author":"Groot N","year":"2017","unstructured":"Groot N, de Graeff N, Avcin T, et al.. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. Ann Rheum Dis. 2017, 76:1637-41. 10.1136\/annrheumdis-2016-211001","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320909156","article-title":"Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups","volume":"29","author":"Massias JS","year":"2020","unstructured":"Massias JS, Smith EMD, Al-Abadi E, et al.. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. Lupus. 2020, 29:474-81. 10.1177\/0961203320909156","journal-title":"Lupus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519896889","article-title":"Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery","volume":"48","author":"Kim JW","year":"2020","unstructured":"Kim JW, Kim TW, Ryu KH, Park SG, Jeong CY, Park DH. Anaesthetic considerations for patients with antiphospholipid syndrome undergoing non-cardiac surgery. J Int Med Res. 2020, 48:0300060519896889. 10.1177\/0300060519896889","journal-title":"J Int Med Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-020-00976-7","article-title":"Pediatric antiphospholipid syndrome: from pathogenesis to clinical management","volume":"23","author":"Rosina S","year":"2021","unstructured":"Rosina S, Chighizola CB, Ravelli A, Cimaz R. Pediatric antiphospholipid syndrome: from pathogenesis to clinical management. Curr Rheumatol Rep. 2021, 23:10. 10.1007\/s11926-020-00976-7","journal-title":"Curr Rheumatol Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/384453-severe-pediatric-arterial-thrombosis-in-antiphospholipid-syndrome-and-systemic-lupus-erythematosus-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:38:52Z","timestamp":1757331532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/384453-severe-pediatric-arterial-thrombosis-in-antiphospholipid-syndrome-and-systemic-lupus-erythematosus-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.91824","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}